• 1
    Girardin, S. E., Boneca, I. G., Carneiro, L. A., Antignac, A., Jehanno, M., Viala, J., Tedin, K. et al., Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003. 300: 15841587.
  • 2
    Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y. et al., An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003. 4: 702707.
  • 3
    Girardin, S. E., Travassos, L. H., Herve, M., Blanot, D., Boneca, I. G., Philpott, D. J., Sansonetti, P. J. and Mengin-Lecreulx, D., Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 2003. 278: 4170241708.
  • 4
    Travassos, L. H., Girardin, S. E., Philpott, D. J., Blanot, D., Nahori, M. A., Werts, C. and Boneca, I. G., Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004. 5: 10001006.
  • 5
    Girardin, S. E., Tournebize, R., Mavris, M., Page, A. L., Li, X., Stark, G. R., Bertin, J. et al., CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2001. 2: 736742.
  • 6
    Kim, J. G., Lee, S. J. and Kagnoff, M. F., Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect. Immun. 2004. 72: 14871495.
  • 7
    Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R. et al., Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 2004. 5: 11661174.
  • 8
    Hysi, P., Kabesch, M., Moffatt, M. F., Schedel, M., Carr, D., Zhang, Y., Boardman, B. et al., NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 2005. 14: 935941.
  • 9
    McGovern, D. P., Hysi, P., Ahmad, T., van Heel, D. A., Moffatt, M. F., Carey, A., Cookson, W. O. and Jewell, D. P., Association between a complex insertion/deletion polymorphism in NOD1(CARD4) and susceptibility to inflammatory bowel disease. Hum. Mol. Genet. 2005. 14: 12451250.
  • 10
    Inohara, N., Koseki, T., del Peso, L., Hu, Y., Yee, C., Chen, S., Carrio, R. et al., Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 1999. 274: 1456014567.
  • 11
    Yoo, N. J., Park, W. S., Kim, S. Y., Reed, J. C., Son, S. G., Lee, J. Y. and Lee, S. H., Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 2002. 299: 652658.
  • 12
    Ogura, Y., Saab, L., Chen, F. F., Benito, A., Inohara, N. and Nunez, G., Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease. Genomics 2003. 81: 369377.
  • 13
    Nagao, S., Akagawa, K. S., Yamada, K., Yagawa, K., Tokunaga, T. and Kotani, S., Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent. Microbiol. Immunol. 1990. 34: 323335.
  • 14
    Pauleau, A. L. and Murray, P. J., Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol. Cell Biol. 2003. 23: 75317539.
  • 15
    Watanabe, T., Kitani, A., Murray, P. J. and Strober, W., NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 2004. 5: 800808.
  • 16
    Maeda, S., Hsu, L. C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L. and Karin, M., Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005. 307: 734738.
  • 17
    Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G. and Flavell, R. A., Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005. 307: 731734.
  • 18
    Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S. and Nunez, G., Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF{kappa}B. J. Biol. Chem. 2001. 276: 48124818.
  • 19
    Traub, S., Kubasch, N., Morath, S., Kresse, M., Hartung, T., Schmidt, R. R. and Hermann, C., Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J. Biol. Chem. 2004. 279: 86948700.
  • 20
    Yang, S., Tamai, R., Akashi, S., Takeuchi, O., Akira, S., Sugawara, S. and Takada, H., Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 2001. 69: 20452053.
  • 21
    van Heel, D., Ghosh, S., Butler, M., Hunt, K., Lundberg, A., Ahmad, T., McGovern, D. et al., Muramyl dipeptide and Toll-like receptor sensitivity in NOD2 associated Crohn's disease. Lancet 2005. 365: 17941796.
  • 22
    Uehara, A., Yang, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Shibata, K., Sugawara, S. and Takada, H., Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 2005. 7: 5361.
  • 23
    Kobayashi, K., Inohara, N., Hernandez, L. D., Galan, J. E., Nunez, G., Janeway, C. A., Medzhitov, R. and Flavell, R. A., RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002. 416: 194199.
  • 24
    Inohara, N., Koseki, T., Lin, J., del Peso, L., Lucas, P. C., Chen, F. F., Ogura, Y. and Nunez, G., An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 2000. 275: 2782327831.
  • 25
    Abbott, D. W., Wilkins, A., Asara, J. M. and Cantley, L. C., The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 2004. 14: 22172227.
  • 26
    Chen, C. M., Gong, Y., Zhang, M. and Chen, J. J., Reciprocal cross talk between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 2004
  • 27
    Damiano, J. S., Oliveira, V., Welsh, K. and Reed, J. C., Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem. J. 2004 Pt.
  • 28
    Martinon, F., Agostini, L., Meylan, E. and Tschopp, J., Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 2004. 14: 19291934.
  • 29
    Vavricka, S. R., Musch, M. W., Chang, J. E., Nakagawa, Y., Phanvijhitsiri, K., Waypa, T. S., Merlin, D. et al., hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 2004. 127: 14011409.
  • 30
    Kreher, C. R., Dittrich, M. T., Guerkov, R., Boehm, B. O. and Tary-Lehmann, M., CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J. Immunol. Methods 2003. 278: 7993.
  • 31
    Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K. et al., Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 2003. 278: 55095512.